


| Key | % Net Assets |
|---|---|
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 89.2% |
| Name | % Net Assets |
|---|---|
| Lincoln National | 2.7% |
| Merck & Co | 2.7% |
| Nucor | 2.7% |
| JP Morgan | 2.7% |
| Hartford Financial | 2.6% |
| Morgan Stanley | 2.6% |
| Wells Fargo | 2.6% |
| Cigna | 2.6% |
| Apache | 2.6% |
| Pfizer | 2.5% |
No asset data available.
| Date | 09-Nov-2018 |
|---|---|
| NAV | 17.01p |
| Currency | GBP |
| Change | 0.16p |
| % | 0.94% |
| YTD change | 17.01p |
| YTD % | n/a |
| Fund Inception | 01/07/2005 |
|---|---|
| Fund Manager | Richard Brody |
| TER | 1.69 (28-Feb-2014) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research